Details

Autor(en) / Beteiligte

• Garces, Alvaro Henrique Ingles
• de Melo, Andreia Cristina
• Paulino, Eduardo
• Nogueira-Rodrigues, Angélica
• Grazziotin, Rachele
• Reisner, Márcio Lemberg
• Dias, Mariane Sousa Fontes
• Guitmann, Gustavo
• Iglesias, Gustavo
• Ferreira, Carlos Gil
• Mountzios, Giannis
• Tavares, Álvaro A.
• De Mello, Ramon Andrade

Titel

Approach and Management of Cervical Cancer

Ist Teil von

• International Manual of Oncology Practice, p.491-549

Ort / Verlag

Cham: Springer International Publishing

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Cervical cancer (CC) represents the third most commonly diagnosed cancer and the fourth cause of cancer death in women worldwide [GLOBOCAN: Estimated cancer incidence, mortality and prevalence worldwide in 2012 international agency for research on cancer; 2012. Available at: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accessed 27 Dec 2017, 2012]. In 2012, across the world, 528,000 new cases were diagnosed with 266,000 deaths, with 85% of the cases occurring in developing countries (GLOBOCAN: Estimated cancer incidence, mortality and prevalence worldwide in 2012 international agency for research on cancer; 2012. Available at: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accessed 27 Dec 2017, 2012; Mathers C, Boerma T, Ma Fat D: The global burden of disease: 2004 update. World Health Organization, Geneva, Available at: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf. Accessed 27 Dec 2017, 2008; Kamangar F, Dores GM, Anderson WF: J Clin Oncol 24:2137–2150, 2006). In the United States, it is the third most common gynaecologic cancer diagnosed and cause of death among gynaecologic cancers (Siegel R, Naishadham D, Jemal A: CA Cancer J Clin 63:11, 2013). Human papillomavirus (HPV) is central to the development of cervical neoplasia and can be detected in 99.7% of CCs.